Catalyst Wire Dossier Catalyst Wire Dossier

Lu AA21004 (Vortioxetine)

vortioxetine · H. Lundbeck A/S
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lu AA21004 (Vortioxetine), covering 2015-06-23 to 2015-06-23. Get the full timeline:

Most recent: Clinical Trial Update: Relapse-prevention Study With Lu AA21004 (Vortioxetine) in Patients With Generalized Anxiety Disorder [Phase 3]

See pricing